ATP13A2: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
 
Line 30: Line 30:
{{stub}}
{{stub}}
{{No image}}
{{No image}}
__NOINDEX__

Latest revision as of 03:02, 17 March 2025

ATP13A2 (also known as PARK9) is a protein that in humans is encoded by the ATP13A2 gene. It is associated with a form of Parkinson's disease known as Kufor-Rakeb syndrome.

Function[edit]

ATP13A2 is an ATPase associated with various cellular activities (AAA) protein. It is involved in the regulation of lysosome homeostasis, autophagy, and metal ion homeostasis. Mutations in this gene are associated with Kufor-Rakeb syndrome, a form of Parkinson's disease.

Clinical significance[edit]

Mutations in ATP13A2 are associated with Kufor-Rakeb syndrome, a form of Parkinson's disease. This condition is characterized by Parkinsonism, supranuclear palsy, pyramidal syndrome, and cognitive decline. ATP13A2 mutations have also been associated with neuronal ceroid lipofuscinosis and hereditary spastic paraplegia.

Genetics[edit]

The ATP13A2 gene is located on the long (q) arm of chromosome 1 at position 36.13. The gene spans approximately 73 kilobases and comprises 29 exons. The encoded protein is 1,180 amino acids in length.

See also[edit]

References[edit]

<references />

External links[edit]

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia